Eye Journal
Hydroxychloroquine retinopathy: an emerging problem – (Eye Journal AOP)
Hydroxychloroquine retinopathy: an emerging problem Eye advance online publication, February 10 2017. doi:10.1038/eye.2016.297 Authors: M Latasiewicz, H Gourier, I H Yusuf, R Luqmani, S M Sharma & S M Downes
Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study – (Eye Journal AOP)
Association between open-angle glaucoma and neovascular age-related macular degeneration: a case-control study Eye advance online publication, February 10 2017. doi:10.1038/eye.2016.325 Authors: C-C Hu, J-D Ho, H-C Lin & L-T Kao
One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration – (Eye Journal AOP)
One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration Eye advance online publication, February 10 2017. doi:10.1038/eye.2017.6 Authors: H Almuhtaseb, S Kanavati, S R Rufai & A J Lotery
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option – (Eye 31, 342 (February 2017))
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option Eye 31, 342 (February 2017). doi:10.1038/eye.2016.233 Authors: M Ashraf, A Souka, R Adelman & S H Forster
Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ – (Eye 31, 345 (February 2017))
Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ Eye 31, 345 (February 2017). doi:10.1038/eye.2016.242 Authors: E H C van Dijk & C J F Boon